Structure Therapeutics, Inc. (GPCR)
49.82
+0.81
(+1.65%)
USD |
NASDAQ |
Aug 25, 10:31
Structure Therapeutics Market Cap : 3.548B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.490B |
| August 21, 2026 | 3.496B |
| August 20, 2026 | 3.598B |
| August 19, 2026 | 3.855B |
| August 18, 2026 | 3.812B |
| August 17, 2026 | 3.829B |
| August 14, 2026 | 3.882B |
| August 13, 2026 | 3.896B |
| August 12, 2026 | 3.839B |
| August 11, 2026 | 3.713B |
| August 10, 2026 | 3.832B |
| August 07, 2026 | 3.785B |
| August 06, 2026 | 3.748B |
| August 05, 2026 | 3.599B |
| August 04, 2026 | 3.528B |
| August 03, 2026 | 3.437B |
| July 31, 2026 | 3.414B |
| July 30, 2026 | 3.516B |
| July 29, 2026 | 3.365B |
| July 28, 2026 | 3.404B |
| July 27, 2026 | 3.460B |
| July 24, 2026 | 3.491B |
| July 23, 2026 | 3.610B |
| July 22, 2026 | 3.583B |
| July 21, 2026 | 3.507B |
| Date | Value |
|---|---|
| July 20, 2026 | 3.339B |
| July 17, 2026 | 3.445B |
| July 16, 2026 | 3.271B |
| July 15, 2026 | 3.526B |
| July 14, 2026 | 3.595B |
| July 13, 2026 | 3.670B |
| July 10, 2026 | 3.792B |
| July 09, 2026 | 3.919B |
| July 08, 2026 | 3.901B |
| July 07, 2026 | 4.025B |
| July 06, 2026 | 3.891B |
| July 02, 2026 | 3.799B |
| July 01, 2026 | 3.704B |
| June 30, 2026 | 3.814B |
| June 29, 2026 | 3.674B |
| June 26, 2026 | 3.533B |
| June 25, 2026 | 3.429B |
| June 24, 2026 | 3.423B |
| June 23, 2026 | 3.241B |
| June 22, 2026 | 3.234B |
| June 18, 2026 | 3.163B |
| June 17, 2026 | 3.198B |
| June 16, 2026 | 3.050B |
| June 15, 2026 | 3.061B |
| June 12, 2026 | 3.051B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.184T |
| Novo Nordisk A/S | 160.20B |
| Pfizer Inc. | 160.77B |
| Tarsus Pharmaceuticals, Inc. | 3.150B |
| Johnson & Johnson | 656.43B |
Market Cap Related Metrics
| Price to Book Value | 2.620 |
| Price | 49.82 |
| Earnings Yield | -6.18% |